Isis-681257 (galnac3--conjugated Aso Targeting Human Lipoprotein (a)) Free Acid
Isis-681257 (galnac3--conjugated Aso Targeting Human Lipoprotein (a)) Free Acid Uses, Dosage, Side Effects, Food Interaction and all others data.
Isis-681257 (galnac3--conjugated Aso Targeting Human Lipoprotein (a)) Free Acid is under investigation in clinical trial NCT03070782 (Phase 2 Study of ISIS 681257 (Akcea-apo(a)-lrx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease).
| Trade Name | Isis-681257 (galnac3--conjugated Aso Targeting Human Lipoprotein (a)) Free Acid |
| Generic | Pelacarsen |
| Pelacarsen Other Names | AKCEA-APO(a)-LRx, IONIS-APO(a)-LRx, Isis-681257 (galnac3--conjugated aso targeting human lipoprotein (a)) free acid, Pelacarsen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Isis-681257 (galnac3--conjugated Aso Targeting Human Lipoprotein (a)) Free Acid
